• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elimination of cefmenoxime during continuous haemofiltration.

作者信息

Evers J, Borner K, Koeppe P

机构信息

Medizinische Klinik I, Stadt Köln-Merheim, Germany.

出版信息

Eur J Clin Pharmacol. 1993;44 Suppl 1:S31-2. doi: 10.1007/BF01428389.

DOI:10.1007/BF01428389
PMID:8486144
Abstract

The elimination of cefmenoxime after single and repeated i.v. dosing was studied in 12 patients with severe renal failure and sepsis during continuous haemofiltration. More than 30% of the drug was found in the filtrate. The sieving coefficient (S) was 0.54. Vss% was unchanged 0.31 l.kg-1 in comparison with patients with normal renal function, whereas the mean t1/2ss was prolonged to about 16 h, and total clearance was reduced 20.8 ml.min-1.1.73 m-2. Once daily administration of 1 g cefmenoxime is suggested as the appropriate dose under such circumstances.

摘要

相似文献

1
Elimination of cefmenoxime during continuous haemofiltration.
Eur J Clin Pharmacol. 1993;44 Suppl 1:S31-2. doi: 10.1007/BF01428389.
2
Pharmacokinetics of ranitidine in patients undergoing haemofiltration.雷尼替丁在接受血液滤过治疗患者中的药代动力学
Eur J Clin Pharmacol. 1988;35(4):427-30. doi: 10.1007/BF00561377.
3
[Pharmacokinetics of cefmenoxime in renal-failure patients undergoing continuous arteriovenous hemofiltration].[头孢甲肟在接受连续性动静脉血液滤过的肾衰竭患者中的药代动力学]
Jpn J Antibiot. 1988 Mar;41(3):338-41.
4
Hemofiltrability of H2-receptor antagonist, famotidine, in renal failure patients.H2受体拮抗剂法莫替丁在肾衰竭患者中的血液滤过性能
J Clin Pharmacol. 1990 Feb;30(2):159-62. doi: 10.1002/j.1552-4604.1990.tb03456.x.
5
Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.危重患者持续肾脏替代治疗期间头孢吡肟的药代动力学
Antimicrob Agents Chemother. 2001 Nov;45(11):3148-55. doi: 10.1128/AAC.45.11.3148-3155.2001.
6
Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.头孢甲肟在肾功能受损患者及接受血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1986 Dec;30(6):901-5. doi: 10.1128/AAC.30.6.901.
7
Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间头孢甲肟的药代动力学
Eur J Clin Pharmacol. 1986;30(6):713-7. doi: 10.1007/BF00608221.
8
Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.急性肾衰竭患者在接受持续静脉-静脉血液滤过治疗时环丙沙星的药代动力学:合并肝硬化的影响
Acta Med Austriaca. 2002;29(3):112-6. doi: 10.1046/j.1563-2571.2002.02017.x.
9
Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.持续静脉-静脉血液透析滤过和持续静脉-静脉血液滤过对氟康唑药代动力学的影响。
Eur J Clin Pharmacol. 2000 Dec;56(9-10):671-8. doi: 10.1007/s002280000216.
10
Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltration.促红细胞生成素(重组人促红细胞生成素)在接受血液透析和血液滤过的患者长期治疗后的药代动力学。
Clin Pharmacokinet. 1993 Aug;25(2):145-53. doi: 10.2165/00003088-199325020-00007.

引用本文的文献

1
Cefotiam during continuous haemofiltration.持续血液滤过期间的头孢替安
Eur J Clin Pharmacol. 1993;44(5):509-10. doi: 10.1007/BF00315555.

本文引用的文献

1
Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.
Eur J Clin Microbiol. 1983 Feb;2(1):17-21. doi: 10.1007/BF02019917.
2
Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.头孢甲肟在健康志愿者、肾功能不全患者及血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1984 Dec;26(6):845-9. doi: 10.1128/AAC.26.6.845.